83 related articles for article (PubMed ID: 2577328)
1. Anti-Thy-1 in bone marrow transplantation.
Thierfelder S; Kummer U; Hoffmann-Fezer G
Immunol Ser; 1989; 45():531-72. PubMed ID: 2577328
[No Abstract] [Full Text] [Related]
2. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R
Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
[TBL] [Abstract][Full Text] [Related]
3. Transplantation tolerance following conditioning with C1q-affinity anti-Thy-1 monoclonal antibodies.
Thierfelder S; Kummer U; Schuh R
Transplant Proc; 1987 Feb; 19(1 Pt 1):459-61. PubMed ID: 3274806
[No Abstract] [Full Text] [Related]
4. Dominant role of Mlsa antigens in the induction of unresponsiveness to non-H-2 antigens.
Berumen L; Pritchard LL; Goutner A; Halle-Pannenko O
Transplant Proc; 1987 Feb; 19(1 Pt 1):506-7. PubMed ID: 3152703
[No Abstract] [Full Text] [Related]
5. An allogeneic immunosuppressive monoclonal anti-T cell antibody can elicit neutralizing anti-antibodies in mice.
Kremmer E; Mysliwietz J; Lederer R; Thierfelder S
Transplant Proc; 1993 Feb; 25(1 Pt 1):842-3. PubMed ID: 8094918
[No Abstract] [Full Text] [Related]
6. Allogeneic bone marrow transplantation in newborn mice treated pre- and post-natally with anti-THY 1.2 monoclonal antibody.
Culver KW; Smith WL; Cowan MJ
Transplant Proc; 1989 Feb; 21(1 Pt 3):2939. PubMed ID: 2565065
[No Abstract] [Full Text] [Related]
7. Evidence that initial T cell depletion suppresses antiantibody formation and preserves immunosuppression after polyclonal ATG.
Thienfelder S; Hoffmann-Fezer G; Kremmer E
Transplantation; 1989 Sep; 48(3):511-4. PubMed ID: 2571208
[No Abstract] [Full Text] [Related]
8. In vivo immunosuppression by pan-T cell antibodies relates to their isotype and to their C1q uptake.
Kummer U; Thierfelder S; Hoffmann-Fezer G; Schuh R
J Immunol; 1987 Jun; 138(12):4069-74. PubMed ID: 2884259
[TBL] [Abstract][Full Text] [Related]
9. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
[TBL] [Abstract][Full Text] [Related]
10. Cellular engineering through marrow transplantation.
Good RA; Kapoor N; Day NK; Reisner Y
Prog Clin Biol Res; 1984; 149():271-98. PubMed ID: 6146143
[No Abstract] [Full Text] [Related]
11. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
[TBL] [Abstract][Full Text] [Related]
12. Antilymphocytic antibodies and marrow transplantation. VI. Absence of immunosuppression in vivo after injection of monoclonal antibodies blocking graft-versus-host reactions and humoral antibody formation in vitro.
Thierfelder S; Hoffmann-Fezer G; Rodt H; Doxiadis I; Eulitz M; Kummer U
Transplantation; 1983 Mar; 35(3):249-54. PubMed ID: 6340277
[TBL] [Abstract][Full Text] [Related]
13. Treatment of murine lymphoma with anti-Thy-1.1 antibodies.
Badger CC; Bernstein ID
Immunol Ser; 1989; 45():515-29. PubMed ID: 2577327
[No Abstract] [Full Text] [Related]
14. Veto cells are not responsible for alloimmunization-induced abrogation of lethal graft-versus-host reaction.
Halle-Pannenko O; Bruley-Rosset M; Pritchard LL
Transplant Proc; 1987 Feb; 19(1 Pt 1):549-50. PubMed ID: 2978923
[No Abstract] [Full Text] [Related]
15. Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
Slavin S; Or R; Naparstek E; Weiss L; Mumcuoglu M; Weshler Z; Brautbar H; Cividalli G; Glikson M; Hale G
Transplant Proc; 1987 Feb; 19(1 Pt 3):2614-5. PubMed ID: 3274569
[No Abstract] [Full Text] [Related]
16. Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism.
Ito H; Takeuchi Y; Shaffer J; Sykes M
Transplantation; 2006 Jul; 82(2):251-7. PubMed ID: 16858289
[TBL] [Abstract][Full Text] [Related]
17. Peripheral tolerance specific for host minor histocompatibility antigens in acute GVHR-protected mice is associated with functional deletion of CD4+ but not CD8+ T cells and an active suppressive mechanism.
Miconnet I; Bruley-Rosset M; Halle-Pannenko O
Transplant Proc; 1993 Feb; 25(1 Pt 1):327-8. PubMed ID: 8438320
[No Abstract] [Full Text] [Related]
18. Cellular basis of acquired immunologic tolerance following total bowel transplantation in rats. I. Relation between donor lymphocyte chimerism and host-cell-mediated immunity.
Masaki Y; Kimura H; Oohara T
Transplant Proc; 1995 Apr; 27(2):1585-8. PubMed ID: 7536971
[No Abstract] [Full Text] [Related]
19. Donor bone marrow in laryngeal transplantation: results of a rat study.
Khariwala SS; Dan O; Lorenz RR; Klimczak A; Siemionow M; Strome M
Am J Otolaryngol; 2008; 29(4):242-9. PubMed ID: 18598835
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
